In separate large obesity trials, semaglutide 2.4mg led to 14.9% mean weight loss at 68 weeks in STEP-1 (n=1,961), while tirzepatide 15mg led to 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (n=2,539)
HSDD is estimated to affect about 10% of women in the United States, according to a 2022 review in CNS Spectrums , and Vyleesi is one of only two FDA-approved therapies specifically indicated for female sexual desire
Quick comparison: Hims vs Henry Meds vs Ivim Health Pricing reflects mid-2026 reports and changes often
28, 2024 /PRNewswire-PRWeb/ -- Options Medical Weight Loss, the nation's premier medical weight loss clinic and provider of medical weight loss solutions, is proud to announce its first clinic in the Metro Atlanta area and first in Georgia at 10800 Alpharetta Highway, Ste 212, Roswell, GA, 30076
Katie Anderson leads the clinical team and protocols are tailored to each patients goals after consultation